Pacira | PCRX - Capital Ordinário





Capital Ordinário Alterar Data
Astellas Pharma JPY 1.79B 109K 2026-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Cara Therapeutics USD 9.38M 2.01K 2026-03
Coherus Biosciences USD 121.16M 4.92M 2025-12
Heron Therapeutics USD 188.31M 4.99M 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
J&J USD 2.41B 1.64M 2026-06
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novo Nordisk DKK 4.43B 13.25M 2026-06
Omeros USD 611K 17K 2023-12
Pacira USD 39.82M 512K 2026-06
Perrigo USD 138.8M 700K 2026-09
Pfizer USD 5.7B 0 2026-06
Supernus Pharmaceuticals USD 58.16M 124K 2026-06
Teva Pharmaceutical Industries USD 1.17B 2M 2026-09
Xeris Pharmaceuticals USD 173.59M 1.03M 2026-06
Zoetis USD 407.49M 6.67M 2026-09